MENU
RYTM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Rhythm Pharmaceuticals (RYTM) Ownership - Who owns Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
222 Berkeley Street
Phone
+1 857 264-4280
Employees
414
Web
https://www.rhythmtx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.96B
P/E Ratio
N/A
Total Cash
340.63M
Projected Growth
N/A
Total Debt
3.84M
Revenue
217.17M
Risk (Beta)
1.24
Dividend Yield
N/A
Total Cash/Share
4.97
Total Debt/Equity
N/A
Revenue/Share
3.28 USD as % of share price
View a ticker or compare two or three
RYTM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of peptide therapeutics for metabolic diseases

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
222 Berkeley Street
Phone
+1 857 264-4280
Employees
414
Web
https://www.rhythmtx.com